Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA name
hsa-miR-619-5p
Specific or universal ncRNAs
Specific ncRNAs
Class
MicroRNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
ATXN3
Cancer name
Oral Squamous Cell Carcinoma
Cancer site
qRT-PCR,Western blot,Dual-luciferase assay
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
Involvement of miR-619-5p in resistance to cisplatin by regulating ATXN3 in oral squamous cell carcinoma
Tissue resource
non-metastatic primary ovarian squamous cell carcinoma tissues and adjacent non-tumoral
human ovarian squamous cell carcinoma cell lines HOK
human ovarian squamous cell carcinoma cell lines Leuk-1
human ovarian squamous cell carcinoma cell lines HN4
human ovarian squamous cell carcinoma cell lines HN6
human ovarian squamous cell carcinoma cell lines CAL27
human ovarian squamous cell carcinoma cell lines UMSCC38
Experiment
None
Institute
Stomatological Collage of Nanjing Medical University
American Type Culture Collection
Country
China
United States
Continent
Asia
North Amercian
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.